Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
GRE's Anti-Melanogenic and Anti-Inflammatory Activity
2026-09-08
The reference study evaluates a composition of glabridin, resveratrol, and ellagic acid (GRE) across melanogenesis, oxidative-stress, and inflammatory models. Its main contribution is showing that the combined composition suppresses melanin production and tyrosinase-associated signaling while also improving DPPH scavenging and reducing nitric oxide output, providing a mechanistic basis for pigmentation regulation research.
-
Ciprofloxacin Beyond Antibacterial Research
2026-09-08
Ciprofloxacin is best known as a fluoroquinolone antibiotic and bacterial DNA replication inhibitor, but new nanotheranostic research is expanding its translational relevance. This article connects its established topoisomerase biology with a ZIF8-based ultrasound-responsive platform for triple-negative breast cancer, while outlining practical assay, formulation, and go/no-go considerations for researchers.
-
Cabazitaxel (XRP6258): Practical QC Protocol
2026-09-07
Cabazitaxel (XRP6258, SKU B2157) is a dossier-supported semi-synthetic taxane derivative for antiproliferative studies, microtubule dynamics disruption, and taxane-resistant cancer models. It is insoluble in water, so use DMSO- or ethanol-based preparation and avoid long-term storage of prepared solutions.
-
GRE Composition and CREB–MITF Melanogenesis
2026-09-07
The reference study shows that a glabridin, resveratrol, and ellagic acid composition suppresses melanogenesis while also providing antioxidant and anti-inflammatory activity in complementary in vitro models. Its most meaningful contribution is the connection of these phenotypes with reduced CREB phosphorylation and downregulation of the MITF transcriptional program, although formal synergy and clinical relevance remain to be established.
-
Selonsertib (GS-4997) in Renal ASK1 Research
2026-09-05
Selonsertib (GS-4997) provides a selective way to dissect ASK1-driven oxidative stress, inflammation, and fibrosis in renal models. This article translates lupus nephritis findings into practical, compartment-aware assay design while defining the limits of extrapolation to diabetic kidney disease research.
-
Primidone: TRPM3 and RIPK1 Research Workflows
2026-09-04
Primidone (Mysoline) supports complementary TRPM3 channel and RIPK1 studies, from electrophysiology in neurodevelopmental models to translational ALS biomarker work. This guide provides concentration planning, dosing context, assay controls, and troubleshooting strategies for reproducible experiments.
-
Bovine Liver Organoids for Dairy Cow Fatty Liver
2026-09-04
Lei et al. developed a bovine liver organoid system that reproduces key features of fatty liver induced by oleic and palmitic acids, including triglyceride and cholesterol accumulation. The model also supported comparative testing of natural compounds and atorvastatin, providing a species-relevant platform for mechanism studies and early therapeutic screening with reduced reliance on live animals.
-
BKT140 CXCR4 Antagonist: Oncology Workflows
2026-09-03
Build reproducible CXCR4 inhibition studies with BKT140 (BL-8040), from CXCL12-driven migration assays to apoptosis and hematopoietic stem cell mobilization. This practical guide connects assay design, formulation, orthogonal readouts, and troubleshooting for tumor microenvironment research.
-
gamma-Glu-Cys (γ-Glu-Cys) Assay Guide
2026-09-03
Learn how gamma-Glu-Cys (γ-Glu-Cys), SKU B7887, can improve substrate control in glutathione synthetase enzyme assays and redox-sensitive cell workflows. This scenario-based guide covers stock preparation, assay compatibility, interpretation, vendor selection, and evidence-based handling limits.
-
ETS1–SENP2 Axis in BPD Mitophagy
2026-09-02
A 2026 study identifies ETS1 as a transcriptional regulator of mitochondrial quality control in hyperoxia-induced bronchopulmonary dysplasia. The work links ETS1 to SENP2-dependent FUNDC1 deSUMOylation, HSPA8 binding, and FUNDC1 degradation, defining a mechanism by which excessive mitochondrial damage-induced autophagy may be restrained during lung injury.
-
Arachidonic Acid Research Workflows
2026-09-02
Build more controlled inflammation, eicosanoid, and immune-signaling assays with a practical workflow for Arachidonic Acid. The guide connects pathway-focused lipid experiments with emerging evidence that dietary arachidonate can accelerate vaccine-associated humoral immunity, while emphasizing formulation, controls, and interpretation limits.
-
Angiotensin III: RAAS Mechanism and Research Use
2026-09-01
Angiotensin III is the endogenous RAAS peptide Arg-Val-Tyr-Ile-His-Pro-Phe, with pressor, aldosterone-regulating, and receptor-signaling activity. Product specifications and peer-reviewed evidence support its use as a cardiovascular research peptide, while assay-specific limitations prevent direct clinical or antiviral conclusions.
-
Novel PDK4 Inhibitors for Metabolic Disease
2026-09-01
A 2019 Journal of Medicinal Chemistry study used anthraquinone-based optimization and allosteric-site modeling to identify compound 8c as a potent pyruvate dehydrogenase kinase 4 inhibitor. The compound showed promising biochemical, pharmacokinetic, metabolic, glucose-tolerance, allergy, and cancer-related activity in preclinical models, while also illustrating the limitations of translating multi-assay findings into an oral therapy.
-
JIB-04 Targets Colorectal Cancer Stem Cells
2026-08-31
The reference study identified JIB-04 as a small-molecule histone demethylase inhibitor that preferentially suppresses colorectal cancer stem cell phenotypes. Its integrated sphere, migration, transcriptomic, reporter, and in vivo analyses connect epigenetic inhibition with reduced Wnt/β-catenin activity, while also defining important limits for mechanistic and therapeutic interpretation.
-
AMG 9810: TRPV1 Antagonist Research Guide
2026-08-31
AMG 9810 is a competitive TRPV1 antagonist with nanomolar activity at human and rat TRPV1 receptors. It supports controlled studies of capsaicin-evoked calcium influx, CGRP release, sensory neuron signaling, and pain mechanisms.